# Effect of Dapagliflozin on LV Remodeling Post AMI

> **NCT04783870** · PHASE4 · UNKNOWN · sponsor: **Instituto Mexicano del Seguro Social** · enrollment: 60 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Dapagliflozin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04783870
- **Lead sponsor:** Instituto Mexicano del Seguro Social
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-03
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04783870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04783870, "Effect of Dapagliflozin on LV Remodeling Post AMI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04783870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*